MedTrace Logo

In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients

NCT02845180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-09-19

No results posted yet for this study

Summary

The purpose of this study is to assess local tissue reaction and retention of an adipose allograft extracellular matrix at 3 or 6 months post-injection into the subcutaneous abdominal tissue of healthy volunteers scheduled to undergo elective panniculectomy.

Conditions

Interventions

PROCEDURE

Adipose Allograft Extracellular Matrix (AAM) Injection

Injection followed by surgery

Sponsors & Collaborators

  • Musculoskeletal Transplant Foundation

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-06-15
Completion
2018-06-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02845180 on ClinicalTrials.gov